Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ophthalmology

Free Subscription Articles published in J Ocul Pharmacol Ther Retrieve available abstracts of 191 articles: HTML format

Single Articles

September 2026
1. PRADOS-CARMONA JJ, Prados-Carmona A, Sanchez-Ventosa A, Villalba-Gonzalez M, et al
   Isotretinoin-Induced Meibomian Gland Dysfunction: Rationale for Proactive Clinical Surveillance.
   J Ocul Pharmacol Ther. 2026;42:395-402.
   PubMed     Abstract available
   
   
   August 2026
2. DABRE Z, Krupa EG, Pasupuleti B, Bacellar-Galdino M, et al
   Ocular Tissue Distribution of Ocular Surface Immunoglobulin Following Topical and Subconjunctival Administration: A Novel Strategy for Mitigation of Antibody-Drug Conjugate-Associated Ocular Toxicity.
   J Ocul Pharmacol Ther. 2026 Aug 6:10807683261475776.
   PubMed     Abstract available
   
   
   
3. CHOPRA AL, Siringoringo C, Siu S, Francis B, et al
   Sustained-Release Intracameral Prostaglandin Analog Implants for Glaucoma: Comparative Review and Meta-Analysis of Bimatoprost and Travoprost Delivery Systems.
   J Ocul Pharmacol Ther. 2026 Aug 3:10807683261474828.
   PubMed     Abstract available
   
   
   
4. CHAMPMARTIN L, Lannoy D, Coulomb M, Jost J, et al
   Standardization of Autologous Serum Eye Drops Preparation Practices in France: Delphi Method.
   J Ocul Pharmacol Ther. 2026;42:356-367.
   PubMed     Abstract available
   
   
   
5. CHEN KY, Chan CM, Chang HC
   Efficacy of Topical Cyclosporine Versus Topical Diquafosol in Treating Dry Eye Disease: A Systematic Review and Meta-Analysis.
   J Ocul Pharmacol Ther. 2026;42:347-355.
   PubMed     Abstract available
   
   
   July 2026
6. LIU Z, Li H, Wang C, Wang T, et al
   Beyond Glycemic Control: Metformin's Multi-Target Role in Preventing and Treating Major Ocular Pathologies.
   J Ocul Pharmacol Ther. 2026 Jul 30:10807683261474426.
   PubMed     Abstract available
   
   
   
7. SALERNO A, Coassin M, Chibret H, Di Zazzo A, et al
   Excipients Beyond Preservatives in Ophthalmic Eye Drops: A Narrative Review with Clinical Implications.
   J Ocul Pharmacol Ther. 2026 Jul 30:10807683261474421.
   PubMed     Abstract available
   
   
   
8. CAGINI C, De Santi N, Solito C, Giugliano M, et al
   In Vivo Evaluation of Preoperative Topical Strategies in Reducing Conjunctival Microbial Load before Intravitreal Injections.
   J Ocul Pharmacol Ther. 2026 Jul 30:10807683261472086.
   PubMed     Abstract available
   
   
   
9. SHEN H, Jin J, Zhang J, Shao W, et al
   Necroptosis Driven by JAK/STAT-RIPK-MLKL Signaling Mediates Corneal Epithelial Erosion.
   J Ocul Pharmacol Ther. 2026 Jul 16:10807683261464756.
   PubMed     Abstract available
   
   
   
10. ZHENG X, Ibrahim AS, Srinivas SP
    Beyond Acute Cytotoxicity: A Repair-Exhaustion Framework for Chronic Sublethal Benzalkonium Chloride Toxicity in Repeated Ophthalmic Exposure.
    J Ocul Pharmacol Ther. 2026 Jul 15:10807683261466785.
    PubMed     Abstract available
    
    
    
11. FUKUDA M, Sasaki Y, Kiyoi T, Ishida H, et al
    Changes in Corneal Epithelial Barrier Function and Zonula Occludens-1 Distribution with Concomitant Use of Silver Nitrate and Latanoprost in Rabbits.
    J Ocul Pharmacol Ther. 2026 Jul 14:10807683261469380.
    PubMed     Abstract available
    
    
    
12. HIREMATH MS, Varkala M, Malani M, Singh S, et al
    Ocular Toxicity of Systemic 5-Fluorouracil Chemotherapy: Role of Lacrimal Gland Transporters.
    J Ocul Pharmacol Ther. 2026 Jul 13:10807683261467574.
    PubMed     Abstract available
    
    
    
13. NORK TM, Sonnentag PJ, Miller PE, Wabers HD, et al
    Preexisting Fundus Findings in a Large Cohort of Young Cynomolgus Macaques (Macaca fascicularis) Bred for Ocular Research: Comparison to Humans.
    J Ocul Pharmacol Ther. 2026 Jul 13:10807683261466791.
    PubMed     Abstract available
    
    
    
14. PESSUTI CL, Huang CL, Banks A, Vo N, et al
    Proteomic Profile Analysis of Plasma and Aqueous Humor from Glaucoma and Nonglaucomatous Patients.
    J Ocul Pharmacol Ther. 2026 Jul 7:10807683261460687.
    PubMed     Abstract available
    
    
    
15. ABUKHALED Y, Alkhateeb A, Abu Serhan H
    Not All that Clouds Is Infection: Intravitreal Precipitation after Sequential Antibiotic Injection.
    J Ocul Pharmacol Ther. 2026 Jul 3:10807683261467743.
    PubMed     Abstract available
    
    
    
16. KOH J
    Physicochemical Fingerprinting of Cyclosporine A Ophthalmic Emulsions as a New Approach Methodology for Clinical Tolerability.
    J Ocul Pharmacol Ther. 2026 Jul 1:10807683261466540.
    PubMed     Abstract available
    
    
    
17. PICHI F, Shehab R, Neri P
    Body Composition and Body Mass Index Show Comparable Associations with Adalimumab Exposure and Immunogenicity in Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2026 Jul 1:10807683261466538.
    PubMed     Abstract available
    
    
    June 2026
18. ZHENG L, Jiang J, Li J, Su X, et al
    Integrated Bioinformatics and Explainable Machine Learning Analyses Reveal Mesenchymal Stem Cell Exosome-Related Biomarkers for Diabetic Retinopathy.
    J Ocul Pharmacol Ther. 2026 Jun 18:10807683261460674.
    PubMed     Abstract available
    
    
    
19. MILLER CW, Scroggins CA, Wuller SL, Hegarty MJ, et al
    Real-World Anatomical Outcomes of Suprachoroidal Triamcinolone Acetonide Injections in a Large Retinal Practice over a 4-Year Period.
    J Ocul Pharmacol Ther. 2026 Jun 12:10807683261461177.
    PubMed     Abstract available
    
    
    
20. MOHAMED MSA
    Soluble Guanylate Cyclase Modulators in Glaucoma and Ocular Fibrosis: Mechanisms, Translational Evidence, and Therapeutic Challenges.
    J Ocul Pharmacol Ther. 2026 Jun 11:10807683261459859.
    PubMed     Abstract available
    
    
    
21. NGUYEN A, Zhu AY, Khouri AS
    Geroprotective Agents, Including Glucagon-Like Peptide-1 Receptor Agonists, for Ocular Health.
    J Ocul Pharmacol Ther. 2026 Jun 11:10807683261456222.
    PubMed     Abstract available
    
    
    
22. JHANWAR M, Goyal S, Nathan A
    Comparative Efficacy and Safety of Topical Bepotastine Besilate 1.5% Versus Sodium Cromoglycate 4% in Chronic Allergic Conjunctivitis: A Prospective Study.
    J Ocul Pharmacol Ther. 2026 Jun 10:10807683261457779.
    PubMed     Abstract available
    
    
    
23. MASKILL D, Blizzard RM, Okonkwo A
    Human Milk in Dry Eye Disease: A Narrative Review with Historical Translation from the Ebers Papyrus.
    J Ocul Pharmacol Ther. 2026;42:280-288.
    PubMed     Abstract available
    
    
    
24. MASUDA T, Sato M, Arakawa R
    PPARalpha-Dependent and Independent Mechanisms Are Complexly Involved in the Ameliorative Effect of a Dietary Supplement Containing Lactic Acid Bacteria in a Dry Eye Mouse Model.
    J Ocul Pharmacol Ther. 2026;42:306-313.
    PubMed     Abstract available
    
    
    May 2026
25. HOFMANN AC, Sinha NR, Hurtado A, Davis AR, et al
    Pirfenidone Inhibits Inflammatory Mediators in Human Cornea In Vitro.
    J Ocul Pharmacol Ther. 2026 May 29:10807683261452067.
    PubMed     Abstract available
    
    
    
26. REEKIE IR, Ramm L, Al-Abadi E, Gurney SP, et al
    Systemic Infliximab Is Efficacious for the Control of Pediatric Uveitis Including in Adalimumab-Refractory Patients.
    J Ocul Pharmacol Ther. 2026 May 26:10807683261454323.
    PubMed     Abstract available
    
    
    
27. MOTAFEGHI F, Ghassemi Barghi E, Gholami Gharab J, Ghassemi Barghi N, et al
    Integrative Mechanistic Insights into Benzalkonium Chloride-Induced Cytotoxicity in Human Corneal Epithelial Cells.
    J Ocul Pharmacol Ther. 2026 May 26:10807683261454329.
    PubMed     Abstract available
    
    
    
28. SAKATA H, Kanzaki S, Kai H, Morii H, et al
    Effects of Inhalation of Hydrogen Gas on Allergic Conjunctivitis Model Mice.
    J Ocul Pharmacol Ther. 2026;42:244-250.
    PubMed     Abstract available
    
    
    
29. MALEK G
    Mini-Series Title: "Nuclear Receptors in Ocular Health and Disease: Therapeutic Horizons from Cornea to Retina" Title: "Nuclear Receptors: The Eye's Hidden Gatekeepers of Inflammation, Lipids, and Repair" Part 1: Setting the Stage.
    J Ocul Pharmacol Ther. 2026;42:219-222.
    PubMed    
    
    
    April 2026
30. ZHAO X, Wang X, Chen S, Tong Y, et al
    Inhibition of Corneal Neovascularization and Pharmacokinetic Study of Cyclodextrin Inclusion of Oroxin B Eye Drops.
    J Ocul Pharmacol Ther. 2026 Apr 29:10807683261429001.
    PubMed     Abstract available
    
    
    
31. FUKUDA M, Sasaki Y, Kiyoi T, Ishida H, et al
    Investigation of Corneal Epithelial Tight Junction Disruption and Barrier Function Impairment Induced by Benzalkonium Chloride.
    J Ocul Pharmacol Ther. 2026 Apr 23:10807683261441060.
    PubMed     Abstract available
    
    
    
32. JU S, Kim J, Park JY, Song JY, et al
    Dose-Dependent Corneal Epithelial and Neural Toxicity of Topical Proparacaine: An In Vivo and In Vitro Study.
    J Ocul Pharmacol Ther. 2026 Apr 21:10807683261445164.
    PubMed     Abstract available
    
    
    
33. YE Y, Long J, Hu P, Shen J, et al
    SDF-1 Inhibition Attenuates VEGF-Driven Retinal Leukostasis and Neovascularization in Ischemic Retinopathy.
    J Ocul Pharmacol Ther. 2026 Apr 10:10807683261441054.
    PubMed     Abstract available
    
    
    
34. HU S, Li X, Zhang X, Bu F, et al
    Advanced Medicinal Treatment for Keratoconus: A Systematic Review of New Drugs and Formulations.
    J Ocul Pharmacol Ther. 2026 Apr 8:10807683261431687.
    PubMed     Abstract available
    
    
    
35. HAN T, Wang Y, Peng X, Huang T, et al
    Study on the Effect of Atropinesterase on Intraocular Atropine Metabolism.
    J Ocul Pharmacol Ther. 2026 Apr 5:10807683261438984.
    PubMed     Abstract available
    
    
    
36. SADEGHI J, Ghavidel Yazdi S, Hajali V, Forouzanfar F, et al
    New Methods in Dry Eye Treatment: Platelet-Rich Plasma.
    J Ocul Pharmacol Ther. 2026;42:154-164.
    PubMed     Abstract available
    
    
    March 2026
37. CHANG YC, Yang YC, Chen PH, Wu WC, et al
    All-Trans Retinoic Acid Modulates MicroRNA-129-5p/Hypoxia-Inducible Factor-1alpha/Vascular Endothelial Growth Factor Signaling and Suppresses Ets-1 in Retinal Pigment Epithelial ARPE-19 Cells.
    J Ocul Pharmacol Ther. 2026 Mar 23:10807683261434410.
    PubMed     Abstract available
    
    
    
38. ZHENG Y, Jiang H, Wang J, Zhang Q, et al
    AG1295 Attenuates High-Glucose-Induced Proliferation, Migration, Phenotype Transition, and Interleukin-6 Expression in Human Corneal Stromal Fibroblasts.
    J Ocul Pharmacol Ther. 2026 Mar 18:10807683261433333.
    PubMed     Abstract available
    
    
    
39. FUNG SSM, Campos C, Weiss J, Yermilov I, et al
    Systematic Literature Review on the Effect of Cenegermin on Corneal Sensation and Innervation in Patients with Neurotrophic Keratopathy.
    J Ocul Pharmacol Ther. 2026 Mar 18:10807683261429005.
    PubMed     Abstract available
    
    
    
40. CELIK E, Polat E, Guven F, Yilmaz A, et al
    Vitreous and Serum Levels of IL-1beta and IL-33 in Proliferative Diabetic Retinopathy: Evaluation of Local Versus Systemic Inflammatory Signatures.
    J Ocul Pharmacol Ther. 2026 Mar 17:10807683261433766.
    PubMed     Abstract available
    
    
    
41. BISWAL S, Das D, Sahoo RN, Parmanik A, et al
    New In Situ Gel Eye Formulation Based on Aristoflex and Xanthan Gum in the Management of Glaucoma Disease: Nonclinical Studies.
    J Ocul Pharmacol Ther. 2026 Mar 14:10807683261428957.
    PubMed     Abstract available
    
    
    
42. KRAMM RL, Novack GD
    Basis of Approval for Glaucoma Drugs and Devices: 2003-2025.
    J Ocul Pharmacol Ther. 2026 Mar 1:10807683261422104.
    PubMed    
    
    
    
43. CHEN KY, Chan HC, Chan CM
    Is Methotrexate a Superior Alternative to Steroids or Placebo for Scleritis? A Systematic Review and Meta-Analysis on Efficacy and Safety.
    J Ocul Pharmacol Ther. 2026;42:117-128.
    PubMed     Abstract available
    
    
    
44. YAO Y, Wang Y, Chen L, Guo M, et al
    Drug Repurposing of Octreotide as a Selective Apelin Receptor Antagonist Against Pathological Angiogenesis: Integrated Virtual Screening and Zebrafish Validation.
    J Ocul Pharmacol Ther. 2026;42:139-147.
    PubMed     Abstract available
    
    
    February 2026
45. MACHADO LF, Kawamuro M, Bando A, Sokabe L, et al
    Fixed Triple-Combination Bimatoprost/Brimonidine/Timolol Versus Separate Administration in Glaucoma: Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2026 Feb 25:10807683261421428.
    PubMed     Abstract available
    
    
    
46. YAN B, Wu SN, Chen XD, Yang ZX, et al
    Drug-Related Uveitis: A Real-World Study Based on the Food and Drug Administration Adverse Event Reporting System Database.
    J Ocul Pharmacol Ther. 2026 Feb 24:10807683261421744.
    PubMed     Abstract available
    
    
    
47. TUNON-ROBINSON I, Zhang R, Nguyen AK
    Visual Acuity Outcomes Following Intravitreal Biological Drug-Induced Retinal Vasculitis: An Intelligent Research in Sight Registry Retrospective Exploratory Analysis.
    J Ocul Pharmacol Ther. 2026 Feb 10:10807683251412321.
    PubMed     Abstract available
    
    
    
48. SUSANNA CN, Martines C, Susanna FN, Germano R, et al
    Evaluation of Peak Intraocular Pressure Reduction in the Water-Drinking Test and Safety of Subliminal Subthreshold Laser.
    J Ocul Pharmacol Ther. 2026 Feb 4:10807683261417554.
    PubMed     Abstract available
    
    
    January 2026
49. LABETOULLE M, Benitez Del Castillo JM, Ucakhan-Gunduz O, Boboridis K, et al
    Comparison of Two Preservative-Free Artificial Tears with Sodium Hyaluronate for Relief of Dry Eye Symptoms: A Randomized, Investigator-Masked Study.
    J Ocul Pharmacol Ther. 2026;42:30-37.
    PubMed     Abstract available
    
    
    
50. LANTYER-ARAUJO NL, Park S, Hisey EA, Thomasy SM, et al
    Topical Application of a Novel Harderian-Derived Nonpolar Lipid Prolongs Tear Film Breakup Time in Normal Beagle Dogs.
    J Ocul Pharmacol Ther. 2026;42:38-44.
    PubMed     Abstract available
    
    
    
51. EL-HARAZI SM, Peace JH, Nguyen A, Yuan J, et al
    Safety and Efficacy of AGN-241622 for Presbyopia: Results From a First-in-Human, Phase 1/2, Randomized, Vehicle-Controlled Study.
    J Ocul Pharmacol Ther. 2026;42:21-29.
    PubMed     Abstract available
    
    
    December 2025
52. NGUYEN A, Ramer EB, Robinson MR
    Corneal Endothelial Cell Loss From Anterior Chamber Paracentesis in a Porcine Model.
    J Ocul Pharmacol Ther. 2025 Dec 18. doi: 10.1177/10807683251408349.
    PubMed     Abstract available
    
    
    
53. FINK MK, Gupta S, Kumar R, Sinha PR, et al
    Topical Rho-Associated Protein Kinase Inhibitor HA1077 Reduces Rabbit Corneal Fibrosis and Neovascularization in Vivo.
    J Ocul Pharmacol Ther. 2025 Dec 18. doi: 10.1177/10807683251405622.
    PubMed     Abstract available
    
    
    
54. SHARIF NA, Kulkarni-Chitnis M, Okolie A, Chaudhry SD, et al
    Relaxation of Precontracted Ciliary Artery and Ciliary Muscle In Vitro by Kinin Peptides: Relevance to Retinal Blood Flow and Intraocular Pressure Regulation.
    J Ocul Pharmacol Ther. 2025 Dec 12. doi: 10.1177/10807683251405992.
    PubMed     Abstract available
    
    
    
55. PARK JH, Son Y, Park CY
    Cetalkonium Chloride Induced a Dose-Dependent Toxicity on Corneal Endothelial Cells.
    J Ocul Pharmacol Ther. 2025 Dec 12. doi: 10.1177/10807683251405795.
    PubMed     Abstract available
    
    
    
56. MAKI K, Kimura E, Yamamoto Y, Fuwa M, et al
    The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost, a Novel Dual Agonist of FP and EP3 Receptors, in Monkeys.
    J Ocul Pharmacol Ther. 2025 Dec 12. doi: 10.1177/10807683251401740.
    PubMed     Abstract available
    
    
    November 2025
57. SHETTLE L, Mulaney J, Williams RD, Beck J, et al
    Double-Masked Controlled Trial of H-1337 as a Treatment for Glaucoma and Ocular Hypertension.
    J Ocul Pharmacol Ther. 2025 Nov 4. doi: 10.1177/10807683251393984.
    PubMed     Abstract available
    
    
    
58. DU J, Rong Y, Yu Z, Li Y, et al
    Effects of Intense Pulsed Light Treatment Combined with Meibomian Gland Expression on Post-Laser Corneal Refractive Surgery Dry Eyes.
    J Ocul Pharmacol Ther. 2025 Nov 4. doi: 10.1177/10807683251391082.
    PubMed     Abstract available
    
    
    
59. WU J, Wu H, Zhou B, He X, et al
    Effect of Topical Application of Dexamethasone on CC Chemokine Receptor 3 Expression in Human Pterygium.
    J Ocul Pharmacol Ther. 2025;41:530-543.
    PubMed     Abstract available
    
    
    
60. 
    Corrigendum to: "The Endocannabinoid System: Role in Ocular Physiology and Therapeutic Potential in Eye Diseases: A Narrative Review".
    J Ocul Pharmacol Ther. 2025;41:554.
    PubMed    
    
    
    October 2025
61. LI A, Chang X, Pu Q, Guo X, et al
    Ambroxol is Effective for Corneal Pain in Rats.
    J Ocul Pharmacol Ther. 2025 Oct 27. doi: 10.1177/10807683251391936.
    PubMed     Abstract available
    
    
    
62. ZHOU L, Qin T, Lv Y, Wu Z, et al
    Qiming Granules Ameliorate Diabetic Retinopathy by Regulating the PI3K/Akt Signaling Pathway.
    J Ocul Pharmacol Ther. 2025 Oct 24. doi: 10.1177/10807683251390213.
    PubMed     Abstract available
    
    
    
63. SHARIF NA, Ota T, Taniguchi T, Sasaoka M, et al
    Cutamesine (SA4503) Protects Retinal Ganglion Cells in an Ocular Hypertension Model of Glaucoma Determined Using Detection of Apoptosing Retinal Cells Technology and RBPMS Cell Marker.
    J Ocul Pharmacol Ther. 2025 Oct 24. doi: 10.1177/10807683251389754.
    PubMed     Abstract available
    
    
    
64. HIRUNPATRAVONG P, Uramphorn N, Kasemsup T, Caprioli J, et al
    Comparison of Preoperative Subconjunctival Injection, Intraoperative Subconjunctival Injection, and Soaked Sponges as Mitomycin C Delivery Methods for Trabeculectomy with a 6-Month Follow-Up Period: A Randomized Controlled Pilot Study.
    J Ocul Pharmacol Ther. 2025 Oct 22. doi: 10.1177/10807683251391092.
    PubMed     Abstract available
    
    
    
65. GUPTA S, Kumar R, Tripathi R, Sinha NR, et al
    Carbofuran Exposure Alters Autophagy Flux in Human Cornea In Vitro and Ex Vivo.
    J Ocul Pharmacol Ther. 2025 Oct 20. doi: 10.1177/10807683251388753.
    PubMed     Abstract available
    
    
    
66. ZHOU Z, Zhu J, Deng W, Zhang F, et al
    Mechanisms Underlying the Protective Effects of Piperine on Retinal Pigment Epithelium Cells.
    J Ocul Pharmacol Ther. 2025 Oct 13. doi: 10.1177/10807683251383712.
    PubMed     Abstract available
    
    
    
67. CHEN Y, Zhang S, Zhong Q, Chen S, et al
    Inflammatory Proteins Profiling in Tear Fluid in Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2025 Oct 9. doi: 10.1177/10807683251384447.
    PubMed     Abstract available
    
    
    
68. AL-DWAIRI R, Ahmad AA, Aleshawi A, Al-Bataineh QM, et al
    Associations Between Clinical Parameters and Optical-Physicochemical Properties of Silicone Oil Extracted after Pars Plana Vitrectomy: An In Vitro Analysis of 35 Eyes.
    J Ocul Pharmacol Ther. 2025 Oct 3. doi: 10.1177/10807683251386127.
    PubMed     Abstract available
    
    
    
69. MA H, Liu D, Tang X, Fu Y, et al
    Baicalein in Ophthalmology: Recent Progress and Emerging Therapeutic Applications.
    J Ocul Pharmacol Ther. 2025 Oct 3. doi: 10.1177/10807683251370549.
    PubMed     Abstract available
    
    
    September 2025
70. DMUCHOWSKA DA, Godzien J, Mojsak P, Godlewski A, et al
    Comment on: Changes in Aqueous Humor Cytokines and Metabolomics in Contralateral Eye After Unilateral Cataract Surgery.
    J Ocul Pharmacol Ther. 2025 Sep 19. doi: 10.1177/10807683251380991.
    PubMed     Abstract available
    
    
    
71. RASSI TNO, Amaral DC, Mund E, Pimentel ALM, et al
    Assessing Long-Term Feasibility and Efficacy of Treatments for Retinal Vein Occlusion Macular Edema: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
    J Ocul Pharmacol Ther. 2025 Sep 18. doi: 10.1177/10807683251380974.
    PubMed     Abstract available
    
    
    
72. ZENG F, He H, Huang S, Luo Y, et al
    Brimonidine Topical Eye Drops and Intravitreal Administration Inhibit Form-Deprivation Myopia in Guinea Pigs: Ocular Pharmacokinetics and Irritation.
    J Ocul Pharmacol Ther. 2025 Sep 18. doi: 10.1177/10807683251376438.
    PubMed     Abstract available
    
    
    
73. LEE H, Sharma A, Woo SJ
    Clinical Trials of Aflibercept Biosimilars: A Review.
    J Ocul Pharmacol Ther. 2025;41:363-369.
    PubMed     Abstract available
    
    
    
74. KHOLZODA S, Ozkan G, Dericioglu V, Akkaya Turhan S, et al
    Topical Cyclosporine and Steroid Treatments: A Comparative Approach to Membranous Punctal Stenosis.
    J Ocul Pharmacol Ther. 2025;41:387-396.
    PubMed     Abstract available
    
    
    August 2025
75. YILDIRIM H, Balbaba M, Canleblebici M, Dal A, et al
    Effect of Dasatinib on Oxidative Stress and Neovascularization in Experimental Corneal Neovascularization.
    J Ocul Pharmacol Ther. 2025 Aug 21. doi: 10.1177/10807683251370551.
    PubMed     Abstract available
    
    
    
76. FEKI O, Zhioua-Braham I, Haddar S, Arfaoui A, et al
    The Endocannabinoid System: Role in Ocular Physiology and Therapeutic Potential in Eye Diseases: A Narrative Review.
    J Ocul Pharmacol Ther. 2025 Aug 21. doi: 10.1177/10807683251368650.
    PubMed     Abstract available
    
    
    
77. SHEN M, Xu B
    Rosmarinic Acid Mitigates Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Human Corneal Epithelial Cells as an In Vitro Keratitis Cell Model.
    J Ocul Pharmacol Ther. 2025 Aug 15. doi: 10.1177/10807683251366780.
    PubMed     Abstract available
    
    
    
78. NORK TM, Katz AW, Rasmussen CA, Kim CBY, et al
    Custom-Made Injector for Suprachoroidal Ocular Delivery: Effect of Intraocular Pressure, Volume, and Location on the Distribution of Aqueous Solutions in Rabbits.
    J Ocul Pharmacol Ther. 2025 Aug 8. doi: 10.1177/10807683251366799.
    PubMed     Abstract available
    
    
    
79. LEI J, Zeng L, Gao X, Wang D, et al
    Comparison of Topical Gatifloxacin and Levofloxacin at Different Durations in Eliminating Conjunctival Bacterial Flora.
    J Ocul Pharmacol Ther. 2025 Aug 6. doi: 10.1177/10807683251366114.
    PubMed     Abstract available
    
    
    
80. XIA R, Lin L, Liu Z, Chen W, et al
    Nonsurgical Therapies for Preventing Corneal Scarring: A Systematic Review of the Past Decade.
    J Ocul Pharmacol Ther. 2025 Aug 6. doi: 10.1177/10807683251361725.
    PubMed     Abstract available
    
    
    
81. KHAN H, Aftab OM, Billah MS, Khouri AS, et al
    Beyond the Prostate: A Visionary Study on Ocular Impacts of Benign Prostatic Hyperplasia Drugs.
    J Ocul Pharmacol Ther. 2025 Aug 6. doi: 10.1089/jop.2025.0030.
    PubMed     Abstract available
    
    
    
82. WANG Z, Li G, Lu H, Wang J, et al
    The Efficacy and Safety of Tumor Necrosis Factor alpha Inhibitors in the Treatment of Noninfectious Uveitis: A Systematic Review and Meta-Analysis.
    J Ocul Pharmacol Ther. 2025 Aug 5. doi: 10.1177/10807683251363436.
    PubMed     Abstract available
    
    
    
83. MONTMEAT D, Thouvenin A, Rasamison R, Boudy V, et al
    Physicochemical Properties and Rheological Behavior of Artificial Tears for Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2025 Aug 5. doi: 10.1177/10807683251364169.
    PubMed     Abstract available
    
    
    
84. CHOUDHRY HS, Pei M, Mothy D, Scarfuto J, et al
    Real-World Safety Profile of Cenegermin Per FDA Adverse Event Reporting System.
    J Ocul Pharmacol Ther. 2025;41:339-346.
    PubMed     Abstract available
    
    
    July 2025
85. ROJAS R, Hinkle DM
    Infectious, Immune-Mediated, and Vaccine-Associated Ocular Adverse Events.
    J Ocul Pharmacol Ther. 2025 Jul 30. doi: 10.1177/10807683251363420.
    PubMed    
    
    
    
86. HERBOTS H, Van Os L, Aerts W, Tassignon MJ, et al
    Evaluation of Systemic Exposure to Intracameral Tropicamide 0.02%, Phenylephrine 0.31%, and Lidocaine 1% in Pediatric Cataract Surgery.
    J Ocul Pharmacol Ther. 2025 Jul 18. doi: 10.1177/10807683251359451.
    PubMed     Abstract available
    
    
    
87. ZHOU J, Wang D, Li GC, Huang Q, et al
    GCN5-TFEB Pathway Regulates Inflammation by Tuning Autophagic Degradation of Retinoic Acid-Induced Gene-I in Human Conjunctival Epithelial Cells.
    J Ocul Pharmacol Ther. 2025 Jul 9. doi: 10.1089/jop.2025.0029.
    PubMed     Abstract available
    
    
    June 2025
88. SUN N, Hu X, Wang J, Yao T, et al
    Minichromosome Maintenance Complex Genes Are Candidate Biomarkers of Retinal Degeneration.
    J Ocul Pharmacol Ther. 2025 Jun 27. doi: 10.1089/jop.2025.0047.
    PubMed     Abstract available
    
    
    
89. WANG Q, Peng Y, Wang S, Xu J, et al
    Exploring the Efficacy of AZD6738 in Corneal Neovascularization: Autophagy Enhancement and Angiogenesis Inhibition.
    J Ocul Pharmacol Ther. 2025 Jun 27. doi: 10.1089/jop.2024.0162.
    PubMed     Abstract available
    
    
    
90. SRIKAJORN C, Tiyaboonchai W, Srinivas SP, Thongsuk W, et al
    Mucoadhesive Silk Fibroin Nanoparticles for Drug Delivery to the Ocular Surface.
    J Ocul Pharmacol Ther. 2025 Jun 24. doi: 10.1089/jop.2024.0180.
    PubMed     Abstract available
    
    
    
91. KROSSER S, Grillenberger R, Eickhoff K, Korward J, et al
    Ocular Pharmacokinetics and Biodistribution of Perfluorohexyloctane after Topical Administration to Rabbits.
    J Ocul Pharmacol Ther. 2025 Jun 19. doi: 10.1089/jop.2025.0056.
    PubMed     Abstract available
    
    
    
92. OZGUR A, Ozmen MC, Yalinbas Yeter D, Inan MA, et al
    Antineovascular Effects of Coenzyme Q10 and Vitamin E Combination in Corneal Neovascularization: A Pilot Study.
    J Ocul Pharmacol Ther. 2025 Jun 11. doi: 10.1089/jop.2025.0068.
    PubMed     Abstract available
    
    
    
93. CHU G, Wang J, Wang Z, Cai X, et al
    Autologous Serum from Sjogren's Syndrome Patients Mitigates Ferroptosis in Hyperosmolarity-Induced Corneal Epitheliopathy.
    J Ocul Pharmacol Ther. 2025 Jun 11. doi: 10.1089/jop.2025.0025.
    PubMed     Abstract available
    
    
    
94. PADMANABHAN NAIR A, Machiraju P, Tejwani S, Dinakaran S, et al
    Lower Levels of Endogenous Intraocular Interferon Beta in Patients with Primary Glaucoma.
    J Ocul Pharmacol Ther. 2025 Jun 9. doi: 10.1089/jop.2025.0085.
    PubMed     Abstract available
    
    
    
95. SUN CC, Pan LY, Chen NN, Kuo YK, et al
    Risk and Protective Factors for Ocular Surface Disease in Patients with Type 2 Diabetic Mellitus: A Retrospective Cohort Study.
    J Ocul Pharmacol Ther. 2025 Jun 9. doi: 10.1089/jop.2024.0175.
    PubMed     Abstract available
    
    
    
96. SADRI E, Verachtert A, Parkhurst GD, Echegoyen J, et al
    Durability of Treatment with a Thermomechanical Device in Meibomian Gland Dysfunction: An Observational Extension Study.
    J Ocul Pharmacol Ther. 2025;41:237-243.
    PubMed     Abstract available
    
    
    
97. DOLAN K
    Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Journal of Ocular Pharmacology and Therapeutics.
    J Ocul Pharmacol Ther. 2025;41:229.
    PubMed    
    
    
    May 2025
98. ROY A, Kompella UB
    Rose Bengal-Assisted Photodynamic Antimicrobial Therapy for Keratitis.
    J Ocul Pharmacol Ther. 2025 May 29. doi: 10.1089/jop.2025.0010.
    PubMed     Abstract available
    
    
    
99. LACAU S, Marin A, Bitrian E
    Steroid-Induced Ocular Hypertension in Children: A Review on Risk Factors.
    J Ocul Pharmacol Ther. 2025 May 13. doi: 10.1089/jop.2025.0024.
    PubMed     Abstract available
    
    
    
100. AFTAB OM, Khan H, Aftab B, Haque W, et al
     Corneal Complications: Drug-Induced Deposits and Food and Drug Administration Adverse Event Reporting System Data Insights-A Retrospective Study.
     J Ocul Pharmacol Ther. 2025 May 5. doi: 10.1089/jop.2024.0178.
     PubMed     Abstract available
     
     
     
101. SHARMA A, Sharma PK, Kompella UB
     Lotilaner for Demodex Blepharitis: The Journey from Veterinary Use to Human Medicine.
     J Ocul Pharmacol Ther. 2025;41:173-186.
     PubMed     Abstract available
     
     
     
102. NAVARRO-NARANJO PI, Chacon-Aponte A, Artunduaga-Rodriguez G
     Clinical Results of the Use of a Combined Solution of 0.5% Carboxymethylcellulose, 0.9% Glycerin, and 3% Trehalose for the Treatment of Dry Eye Disease.
     J Ocul Pharmacol Ther. 2025;41:210-216.
     PubMed     Abstract available
     
     
     April 2025
103. FAHMY A, Ahmed M, Pflugfelder S, Serikbaeva A, et al
     Comparative Efficacy of Current Topical Treatments for Dry Eye Disease: A Review of Pivotal Clinical Trials Evaluating Corneal Staining Outcomes.
     J Ocul Pharmacol Ther. 2025 Apr 28. doi: 10.1089/jop.2024.0192.
     PubMed     Abstract available
     
     
     
104. LIU J, Jiang E, Kim H, Moon J, et al
     Beneficial Effect of Rebamipide Eye Drops on Blue Light-Induced Oxidative Damage in the Ocular Surface.
     J Ocul Pharmacol Ther. 2025 Apr 28. doi: 10.1089/jop.2024.0208.
     PubMed     Abstract available
     
     
     
105. SANCHEZ-TOCINO H, Villanueva Gomez A, Saldana Burgos R, Hata Viveiros MM, et al
     Myopia Progression Study Comparing Low-Dose (0.01%) Atropine Eye Drops with a Control Group.
     J Ocul Pharmacol Ther. 2025 Apr 18. doi: 10.1089/jop.2024.0202.
     PubMed     Abstract available
     
     
     
106. QUIRKE M, Lamoureux F, Arnoult C, Gress G, et al
     Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study.
     J Ocul Pharmacol Ther. 2025 Apr 18. doi: 10.1089/jop.2024.0165.
     PubMed     Abstract available
     
     
     
107. PETTY RM, Rangan RS, Curry S, Brooks CD, et al
     Biodistribution of Reconstituted High-Density Lipoprotein Nanoparticles for Targeted Delivery to Retinal Ganglion Cells.
     J Ocul Pharmacol Ther. 2025 Apr 18. doi: 10.1089/jop.2024.0191.
     PubMed     Abstract available
     
     
     
108. DUTRA BAL, Wilson SE
     Topical Losartan in the Management of Corneal Scarring Fibrosis: Update on Dosage, Efficacy, and Potential Epithelial Toxicity.
     J Ocul Pharmacol Ther. 2025 Apr 16. doi: 10.1089/jop.2024.0200.
     PubMed     Abstract available
     
     
     
109. REITINGER JC, Reed DM, Peres C, Fan S, et al
     Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol.
     J Ocul Pharmacol Ther. 2025 Apr 14. doi: 10.1089/jop.2024.0112.
     PubMed     Abstract available
     
     
     
110. JIN H, Yoon HJ, Jiang E, Liu J, et al
     Therapeutic Effects of Human Placental Extracts Eye Drops in Experimental Dry Eye and Alkali Burn.
     J Ocul Pharmacol Ther. 2025;41:141-149.
     PubMed     Abstract available
     
     
     March 2025
111. KISHI A, Bryant AD, Reed DM, Toris CB, et al
     Letter to the Editor: Effect of Aqueous Tears on Topical Fluorescein Tracer Emission Signal from Cornea and Anterior Chamber.
     J Ocul Pharmacol Ther. 2025 Mar 10. doi: 10.1089/jop.2024.0143.
     PubMed    
     
     
     
112. PUTRI LR, Edwar L
     Corticosteroid as Treatment in Infective Conjunctivitis: A Systematic Literature Review and Meta-Analysis.
     J Ocul Pharmacol Ther. 2025 Mar 10. doi: 10.1089/jop.2024.0110.
     PubMed     Abstract available
     
     
     
113. AFTAB OM, Khan H, Bargoud A, Khouri AS, et al
     Are Alpha-2 Adrenergic Agonists Being Used in Infants?
     J Ocul Pharmacol Ther. 2025;41:75-78.
     PubMed     Abstract available
     
     
     February 2025
114. ROUTH BL, Tripathi R, Giuliano EA, Lankau BR, et al
     Effect of Chemical Injury on Autophagy in Canine Corneal Stromal Fibroblasts.
     J Ocul Pharmacol Ther. 2025 Feb 17. doi: 10.1089/jop.2024.0211.
     PubMed     Abstract available
     
     
     
115. ALEKSANDER-IVANOV Y, Amaral DC, Cheidde L, Lima GN, et al
     Safety and Efficacy of 0.1% Cyclosporine Solutions in Dry Eye Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
     J Ocul Pharmacol Ther. 2025 Feb 10. doi: 10.1089/jop.2024.0169.
     PubMed     Abstract available
     
     
     
116. VOUGHT R, Vought V, Crane AB, Khouri AS, et al
     Medicare Part D Glaucoma Drug Prescribing Patterns by Ophthalmologists from 2018 to 2022.
     J Ocul Pharmacol Ther. 2025 Feb 5. doi: 10.1089/jop.2024.0196.
     PubMed     Abstract available
     
     
     
117. HONG S, Woo M, Eom Y, Kim HK, et al
     A Multicenter, Randomized, Clinical Trial Assessing the Effect of rTG-Omega 3 Supplementation on Meibomian Gland Dysfunction Patients after Cataract Surgery rTG-Omega 3 for Meibomian Gland Dysfunction.
     J Ocul Pharmacol Ther. 2025 Feb 5. doi: 10.1089/jop.2024.0160.
     PubMed     Abstract available
     
     
     
118. SADIKAN MZ, Lambuk L, Reshidan NH, Abdul Ghani NA, et al
     Age-Related Macular Degeneration Pathophysiology and Therapeutic Potential of Tocotrienols: An Update.
     J Ocul Pharmacol Ther. 2025 Feb 3. doi: 10.1089/jop.2024.0123.
     PubMed     Abstract available
     
     
     January 2025
119. COSKUN A, Senturk F, Turan E
     Enhanced Transepithelial Riboflavin Delivery Across the Cornea Using Magnetic Nanocarriers.
     J Ocul Pharmacol Ther. 2025 Jan 30. doi: 10.1089/jop.2024.0183.
     PubMed     Abstract available
     
     
     
120. SARKAR T, Gogoi NR, Jana BK, Mazumder B, et al
     Formulation Advances in Posterior Segment Ocular Drug Delivery.
     J Ocul Pharmacol Ther. 2025 Jan 23. doi: 10.1089/jop.2024.0153.
     PubMed     Abstract available
     
     
     
121. CRUZ MRB, Amaral DC, Goncalves OR, Cyrino LG, et al
     Chlorhexidine Compared with Povidone-Iodine in Intravitreal Injection: A Systematic Review and Meta-Analysis.
     J Ocul Pharmacol Ther. 2025 Jan 21. doi: 10.1089/jop.2024.0141.
     PubMed     Abstract available
     
     
     
122. GRESS G, Lamoureux F, Bourgain J, Ganem A, et al
     Selective Tissue Penetration of the Corneal Layers of Cyclosporin 2% Associated with Miglyol in Rabbits.
     J Ocul Pharmacol Ther. 2025 Jan 20. doi: 10.1089/jop.2024.0087.
     PubMed     Abstract available
     
     
     
123. SADIKAN MZ, Lambuk L, Reshidan N, Ahmad Hairi H, et al
     Molecular Mechanisms of Vitamin E in Ocular Neurodegenerative Disorders: An Update on the Emerging Evidence and Therapeutic Implications.
     J Ocul Pharmacol Ther. 2025 Jan 8. doi: 10.1089/jop.2024.0125.
     PubMed     Abstract available
     
     
     
124. HOARAU G, Best AL, Zina-Meziou S, Benali-Abdallah M, et al
     Effects of Intense Pulsed Light on Presumed Neuropathic Pain Associated with Meibomian Gland Dysfunction: A Before-After Study.
     J Ocul Pharmacol Ther. 2025;41:24-32.
     PubMed     Abstract available
     
     
     December 2024
125. IRFAN AMSM, Geoffrey S, Htet H, Krishnappa P, et al
     N-Methyl-d-Aspartate-Induced Excitotoxicity and Its Impact on the Renin-Angiotensin System in Retinal Tissue.
     J Ocul Pharmacol Ther. 2024 Dec 13. doi: 10.1089/jop.2024.0131.
     PubMed     Abstract available
     
     
     
126. KOVALIS N, Graffi S, Safuri S, Shapira Y, et al
     Duration of Bare Sclera Pterygium Surgery Combined with Mitomycin C with and Without Tranexamic Acid: A Randomized Double-Blind Controlled Trial.
     J Ocul Pharmacol Ther. 2024;40:675-679.
     PubMed     Abstract available
     
     
     
127. YAN YL, Chang JY, Ling XR, Xue CY, et al
     Effects of Rebamipide for Dry Eye on Optical Quality and Efficacy: A Systematic Review and Meta-Analysis.
     J Ocul Pharmacol Ther. 2024;40:629-637.
     PubMed     Abstract available
     
     
     
128. WANG N, Yuan K, Yang S, Jin X, et al
     13-cis Retinoic Acid-Mediated Modulation of Human Meibomian Gland Epithelial Cells Development: Implications for In Vitro Modeling of Meibomian Gland Dysfunction.
     J Ocul Pharmacol Ther. 2024;40:659-667.
     PubMed     Abstract available
     
     
     
129. BHUJBAL S, Rupenthal ID, Steven P, Agarwal P, et al
     Inflammation in Dry Eye Disease-Pathogenesis, Preclinical Animal Models, and Treatments.
     J Ocul Pharmacol Ther. 2024;40:638-658.
     PubMed     Abstract available
     
     
     
130. SEETHARAMAN ATM, Owens CE, Gangaraju R
     Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits.
     J Ocul Pharmacol Ther. 2024;40:617-628.
     PubMed     Abstract available
     
     
     November 2024
131. ERB C, Topouzis F, Jayaram H, Allan F, et al
     Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension.
     J Ocul Pharmacol Ther. 2024 Nov 7. doi: 10.1089/jop.2024.0092.
     PubMed     Abstract available
     
     
     
132. ROWE-RENDLEMAN CL
     Regulatory Requirements of Biosimilars: Drug Development in Ophthalmology, Part 1.
     J Ocul Pharmacol Ther. 2024 Nov 4. doi: 10.1089/jop.2024.0151.
     PubMed    
     
     
     
133. NGUYEN A, Naidoo KK, Ajouz L, Xu X, et al
     Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction.
     J Ocul Pharmacol Ther. 2024;40:562-570.
     PubMed     Abstract available
     
     
     October 2024
134. HWANG JS, Song HB, Lee G, Jeong S, et al
     Extracellular Vesicles Derived from Adipose-Derived Mesenchymal Stem Cells Alleviate Apoptosis and Oxidative Stress of Retinal Pigment Epithelial Cells Through Activation of Nrf2 Signaling Pathway.
     J Ocul Pharmacol Ther. 2024 Oct 25. doi: 10.1089/jop.2024.0064.
     PubMed     Abstract available
     
     
     
135. DIBAS A, Batabyal S, Kim S, Carlson M, et al
     Efficacy of Intravitreal Multi-Characteristic Opsin (MCO-010) Optogenetic Gene Therapy in a Mouse Model of Leber Congenital Amaurosis.
     J Ocul Pharmacol Ther. 2024 Oct 23. doi: 10.1089/jop.2024.0084.
     PubMed     Abstract available
     
     
     
136. BOUHAJIB M, Tayab Z, Di Marco C, Suh DD, et al
     Clinical Pharmacokinetics of Atropine Administered Ocularly Using an Ultrasensitive Bioanalytical Assay.
     J Ocul Pharmacol Ther. 2024 Oct 4. doi: 10.1089/jop.2024.0113.
     PubMed     Abstract available
     
     
     
137. SULTAN A, Harris DL, Lam P, Whitcomb J, et al
     The Optejet Technology Minimizes Preservative-Mediated Cytotoxicity of Conjunctival Epithelial Cells Treated with Latanoprost In Vitro.
     J Ocul Pharmacol Ther. 2024 Oct 2. doi: 10.1089/jop.2024.0085.
     PubMed     Abstract available
     
     
     
138. HILL M, Andrews-Pfannkoch C, Atherton E, Knudsen T, et al
     Detection of Residual iPSCs Following Differentiation of iPSC-Derived Retinal Pigment Epithelial Cells.
     J Ocul Pharmacol Ther. 2024 Oct 2. doi: 10.1089/jop.2024.0130.
     PubMed     Abstract available
     
     
     
139. MATSUMOTO R, Obata S, Kakinoki M, Sawada O, et al
     Duration of Vascular Endothelial Growth Factor Suppression after Intravitreal Injection of Faricimab in Macaque Eyes.
     J Ocul Pharmacol Ther. 2024 Oct 2. doi: 10.1089/jop.2024.0138.
     PubMed     Abstract available
     
     
     September 2024
140. JUAN HY, Sheu SJ, Hwang DK
     Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis.
     J Ocul Pharmacol Ther. 2024 Sep 24. doi: 10.1089/jop.2024.0100.
     PubMed     Abstract available
     
     
     
141. LUHAR M, Viradiya R, Panjabi S, Patel G, et al
     Nanotechnology in Ocular Drug Delivery: The Potential of Polymeric Micelles as a Drug Delivery Vehicle.
     J Ocul Pharmacol Ther. 2024 Sep 12. doi: 10.1089/jop.2024.0060.
     PubMed    
     
     
     
142. TSENG KA
     Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Ocular Pharmacology and Therapeutics.
     J Ocul Pharmacol Ther. 2024;40:407.
     PubMed    
     
     
     
143. FUKUDA M, Kiyoi T, Takeda S, Sasaki Y, et al
     Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium.
     J Ocul Pharmacol Ther. 2024;40:428-434.
     PubMed     Abstract available
     
     
     
144. NOVACK GD
     Eyes on New Product Development.
     J Ocul Pharmacol Ther. 2024;40:408-409.
     PubMed    
     
     
     
145. ZHAO Y, Zhang X, Zhou X, Chen B, et al
     IL-22/IL-22RA1 Promotes Human Tenon's Capsule Fibroblasts Proliferation and Regulates Fibrosis Through STAT3 Signaling Pathway.
     J Ocul Pharmacol Ther. 2024;40:435-444.
     PubMed     Abstract available
     
     
     August 2024
146. GAO AY, Whaley MG, Saraf N, Bakri SJ, et al
     Survey of Dopamine Receptor D2 Antagonists as Retinal Antifibrotics.
     J Ocul Pharmacol Ther. 2024 Aug 29. doi: 10.1089/jop.2024.0006.
     PubMed     Abstract available
     
     
     
147. DURRANI AF, Momenaei B, Soni V, Tennant M, et al
     Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.
     J Ocul Pharmacol Ther. 2024 Aug 22. doi: 10.1089/jop.2024.0071.
     PubMed     Abstract available
     
     
     
148. BACHARACH J, McLaurin EB, Silverstein S, Amrane M, et al
     Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.
     J Ocul Pharmacol Ther. 2024 Aug 16. doi: 10.1089/jop.2024.0029.
     PubMed     Abstract available
     
     
     
149. CREAN CS, Yeu E, Maiti S, Neervannan S, et al
     Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits.
     J Ocul Pharmacol Ther. 2024 Aug 16. doi: 10.1089/jop.2024.0074.
     PubMed     Abstract available
     
     
     July 2024
150. WON J, Kang J, Kang W
     Comparative Ocular Pharmacokinetics of Dexamethasone Implants in Rabbits.
     J Ocul Pharmacol Ther. 2024 Jul 24. doi: 10.1089/jop.2024.0052.
     PubMed    
     
     
     
151. HAMEED SS, Bodi NE, Miller RC, Sharma TP, et al
     Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Ex Vivo Human Glaucoma Model.
     J Ocul Pharmacol Ther. 2024 Jul 12. doi: 10.1089/jop.2024.0041.
     PubMed     Abstract available
     
     
     
152. ZEMITIS A, Vanags J, Fan J, Klavins K, et al
     Metabolomic Disparities in Intraocular Fluid Across Varied Stages of Cataract Progression: Implications for the Analysis of Cataract Development.
     J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0067.
     PubMed     Abstract available
     
     
     
153. CHAUVIER J, Trone MC, Gain P, Ollier E, et al
     Corneal Toxicity in Patients Treated by BELANTAMAB MAFODOTIN: How to Improve and Facilitate Patients Follow-Up Using Refractive Shift?
     J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0023.
     PubMed     Abstract available
     
     
     
154. KASHIKAR R, Senapati S, Dudhipala N, Basu SK, et al
     Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application.
     J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0055.
     PubMed     Abstract available
     
     
     
155. DOLAN K, Liao SM, Crowley M, Xiang C, et al
     Complement Factor B Inhibition or Deletion Is Not Sufficient to Prevent Neurodegeneration in a Murine Model of Glaucoma.
     J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0046.
     PubMed     Abstract available
     
     
     
156. ZOR KR, Yilmaz U, Bozkurt SB
     Coenzyme Q10 and Vitamin E Regulate the Bioactivity of Human Corneal Fibroblast Cells.
     J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0050.
     PubMed     Abstract available
     
     
     
157. MENG C, Wei Q, Gu C, He S, et al
     Prevalence and Risk Factors of Ocular Demodex at Ultra-High Altitude and Sea Level: A Cross-Sectional Study of Shigatse and Shanghai.
     J Ocul Pharmacol Ther. 2024 Jul 4. doi: 10.1089/jop.2024.0038.
     PubMed     Abstract available
     
     
     
158. PAGNACCO C, Tosi R, Dalsaso J, Fraccaroli S, et al
     A Prospective, Randomized, Controlled Clinical Investigation Comparing the Efficacy and Safety of Sodium Hyaluronate-Based Ophthalmical Viscosurgical Devices FIDIAL PLUS and IAL((R))-F in Cataract Surgery.
     J Ocul Pharmacol Ther. 2024 Jul 1. doi: 10.1089/jop.2024.0044.
     PubMed     Abstract available
     
     
     
159. YAO Q, Wu H, Ren H, Cao J, et al
     Inhibition of Experimental Corneal Neovascularization by the Tight Junction Protein ZO-1.
     J Ocul Pharmacol Ther. 2024;40:379-388.
     PubMed     Abstract available
     
     
     
160. NOVACK GD
     Eyes on New Product Development.
     J Ocul Pharmacol Ther. 2024;40:325-326.
     PubMed    
     
     
     
161. MICHAEL E, Singh V
     Diagnostic Uses of Common Eye Drops.
     J Ocul Pharmacol Ther. 2024;40:327-331.
     PubMed     Abstract available
     
     
     June 2024
162. KLEINMAN D, Iqbal S, Ghosh AK, Ogle SD, et al
     PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro.
     J Ocul Pharmacol Ther. 2024 Jun 27. doi: 10.1089/jop.2024.0019.
     PubMed     Abstract available
     
     
     
163. VARDAR C, George-Weinstein M, Getts R, Byrne ME, et al
     Evaluation of Dose-Response Relationship in Novel Extended Release of Targeted Nucleic Acid Nanocarriers to Treat Secondary Cataracts.
     J Ocul Pharmacol Ther. 2024 Jun 20. doi: 10.1089/jop.2024.0024.
     PubMed     Abstract available
     
     
     
164. LIU L, Wang S, Blanco T, Ge H, et al
     Neurokinin-1 Receptor Antagonism Reduces Nonallergic Ocular Redness in a Rabbit Model.
     J Ocul Pharmacol Ther. 2024 Jun 3. doi: 10.1089/jop.2024.0003.
     PubMed     Abstract available
     
     
     
165. LEE SS, Nagar S, Rajagopalan L, Orilla W, et al
     Using a Novel, Subconjunctival, Sustained-Release Mitomycin C Formulation in a Rabbit Model of Filtration Surgery with Gel Stent Implantation.
     J Ocul Pharmacol Ther. 2024;40:297-308.
     PubMed     Abstract available
     
     
     
166. NOVACK GD
     Eyes on New Product Development.
     J Ocul Pharmacol Ther. 2024;40:259-260.
     PubMed    
     
     
     May 2024
167. ANDERSON SG, Meyer D, Decloedt EH
     The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit.
     J Ocul Pharmacol Ther. 2024 May 27. doi: 10.1089/jop.2024.0020.
     PubMed     Abstract available
     
     
     
168. NOVACK GD
     Eyes on New Product Development.
     J Ocul Pharmacol Ther. 2024;40:203.
     PubMed    
     
     
     April 2024
169. GUO M, Liu T, Miao Y, Pan X, et al
     Role of NADPH Oxidase 4 on Dry Eye Syndrome in Mice.
     J Ocul Pharmacol Ther. 2024 Apr 26. doi: 10.1089/jop.2024.0002.
     PubMed     Abstract available
     
     
     
170. NERI P, Perez Y, Agarwal A, Pichi F, et al
     Unraveling the Complexities of Severe Acute Respiratory Syndrome Coronavirus 2: A Comprehensive Ophthalmic and Systemic Perspective.
     J Ocul Pharmacol Ther. 2024 Apr 25. doi: 10.1089/jop.2024.0037.
     PubMed     Abstract available
     
     
     
171. BISEN AC, Srivastava S, Mishra A, Sanap SN, et al
     Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.
     J Ocul Pharmacol Ther. 2024 Apr 23. doi: 10.1089/jop.2023.0166.
     PubMed     Abstract available
     
     
     
172. ANAM A, Liu C, Tong L, Liu YC, et al
     Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain.
     J Ocul Pharmacol Ther. 2024 Apr 22. doi: 10.1089/jop.2023.0155.
     PubMed     Abstract available
     
     
     
173. GONZALEZ VH, Uram M, Schupp A, Widmann M, et al
     AG-920 (Articaine) Ophthalmic Solution: A Masked, Active-Controlled Evaluation of Its Local Anesthetic Efficacy and Safety in Pediatric Patients.
     J Ocul Pharmacol Ther. 2024 Apr 22. doi: 10.1089/jop.2023.0187.
     PubMed     Abstract available
     
     
     
174. TRAN HDM, Ha TTX, Tran YH, Coroneo M, et al
     Impact of Various Concentrations of Low-Dose Atropine on Pupillary Diameter and Accommodative Amplitude in Children with Myopia.
     J Ocul Pharmacol Ther. 2024 Apr 15. doi: 10.1089/jop.2023.0173.
     PubMed     Abstract available
     
     
     
175. HUSAIN S, Obert E, Singh S, Schnabolk G, et al
     Inhibition of HDAC1 and 3 in the Presence of Systemic Inflammation Reduces Retinal Degeneration in a Model of Dry Age-Related Macular Degeneration.
     J Ocul Pharmacol Ther. 2024 Apr 12. doi: 10.1089/jop.2023.0163.
     PubMed     Abstract available
     
     
     
176. YADAV KS, Bisen AC, Ishteyaque S, Sharma I, et al
     Solanum nigrum Toxicity and Its Neuroprotective Effect Against Retinal Ganglion Cell Death Through Modulation of Extracellular Matrix in a Glaucoma Rat Model.
     J Ocul Pharmacol Ther. 2024 Apr 11. doi: 10.1089/jop.2023.0089.
     PubMed     Abstract available
     
     
     
177. MISHRA A, Agrawal M, Tripathi A, Bhirud A, et al
     A Comparative Study on Efficacy of Intraocular Pressure Lowering of Two Fixed-Dose Antiglaucoma Drug Combination Brinzolamide-Brimonidine Versus Latanoprost-Timolol in Primary Open-Angle Glaucoma and Ocular Hypertension.
     J Ocul Pharmacol Ther. 2024 Apr 10. doi: 10.1089/jop.2023.0186.
     PubMed     Abstract available
     
     
     
178. DIAS PB, Rodrigues Parchen MDA, Wasilewski D
     Comparison of Proparacaine, Tetracaine, and Oxybuprocaine in Corneal Sensitivity Measurement.
     J Ocul Pharmacol Ther. 2024 Apr 8. doi: 10.1089/jop.2023.0148.
     PubMed     Abstract available
     
     
     
179. GARWEG JG, Pietzuch M, Mantel I, Ambresin A, et al
     Response to the Letter to the Editor by Michael Colucciello, MD, FASRS, Entitled "Steroid/Anti-VEGF Combination Therapy for Neovascular AMD".
     J Ocul Pharmacol Ther. 2024;40:199-200.
     PubMed    
     
     
     
180. NOVACK GD
     Eyes on New Product Development.
     J Ocul Pharmacol Ther. 2024;40:158-159.
     PubMed    
     
     
     
181. WATANABE M, Sato T, Umetsu A, Nishikiori N, et al
     Differential Effects of Benzalkonium Chloride on Human Trabecular Meshwork Cells Not Treated or Treated with Transforming Growth Factor-beta2 or Dexamethasone.
     J Ocul Pharmacol Ther. 2024;40:189-196.
     PubMed     Abstract available
     
     
     
182. GAO J, Wang Y, Han R, Li J, et al
     Elevated KDM4D Expression in Pterygium: Impact and Potential Inhibition by Lycium Barbarum Polysaccharide.
     J Ocul Pharmacol Ther. 2024;40:181-188.
     PubMed     Abstract available
     
     
     March 2024
183. CHENG Y, Liu G
     Evaluation of the Treatment Effects of Conditioned Medium from Human Orbital Adipose-Derived Stem Cells in a Corneal Alkali Burn Rabbit Model.
     J Ocul Pharmacol Ther. 2024 Mar 28. doi: 10.1089/jop.2023.0154.
     PubMed     Abstract available
     
     
     
184. CID-BERTOMEU P, Vilaltella M, Martinez M, Mir M, et al
     Topical Insulin for Ocular Surface Disease.
     J Ocul Pharmacol Ther. 2024 Mar 22. doi: 10.1089/jop.2024.0016.
     PubMed     Abstract available
     
     
     
185. MURAKAMI Y, Imaizumi T, Hashizume K, Tezuka Y, et al
     Inhibition of Connective Tissue Growth Factor Expression in Adult Retinal Pigment Epithelial-19 Cells by Blocking Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Activity.
     J Ocul Pharmacol Ther. 2024 Mar 22. doi: 10.1089/jop.2023.0141.
     PubMed     Abstract available
     
     
     
186. YILMAZ OF, Sarmis A
     Relationship Between Conjunctival Corynebacterium and 5% Sheep Blood Agar.
     J Ocul Pharmacol Ther. 2024 Mar 6. doi: 10.1089/jop.2024.0010.
     PubMed    
     
     
     
187. COLUCCIELLO M
     Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration.
     J Ocul Pharmacol Ther. 2024 Mar 6. doi: 10.1089/jop.2024.0013.
     PubMed    
     
     
     
188. LEE JH, Kim JH
     Impact of Prolonged Persisting Subretinal Fluid on the Outcome of Aflibercept Treatment in Neovascular Age-Related Macular Degeneration.
     J Ocul Pharmacol Ther. 2024;40:136-143.
     PubMed     Abstract available
     
     
     
189. NOVACK GD
     Eyes on New Product Development.
     J Ocul Pharmacol Ther. 2024;40:109-110.
     PubMed    
     
     
     
190. FIGUS M, Giansanti F, Villani E, Alio JL, et al
     Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery.
     J Ocul Pharmacol Ther. 2024;40:117-125.
     PubMed     Abstract available
     
     
     February 2024
191. RUAN M, Wang R, He Y
     Novel Drug Delivery Systems for the Management of Fungal Keratitis.
     J Ocul Pharmacol Ther. 2024 Feb 23. doi: 10.1089/jop.2023.0161.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ophthalmology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum